The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnteq Tech Regulatory News (NTQ)

Share Price Information for Enteq Tech (NTQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.00
Bid: 8.50
Ask: 9.50
Change: 0.00 (0.00%)
Spread: 1.00 (11.765%)
Open: 9.00
High: 9.00
Low: 9.00
Prev. Close: 9.00
NTQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

14 Mar 2019 16:32

RNS Number : 9383S
Enteq Upstream PLC
14 March 2019
 

 

 

Enteq Upstream plc

("Enteq" or the "Company")

 

 

Issue of shares

and

Director/PDMR Shareholding

 

Enteq, the oil and gas drilling technology Company, announces that on 12 March 2019 it issued and allotted 180,126 new ordinary shares of 1p each ("Ordinary Shares") to various Directors in compensation for remuneration due. This compensation was taken in new Ordinary Shares, rather than cash, in line with the Directors support of the Company's policy to preserve cash and their belief in the Company's longer-term potential.

 

These new Ordinary Shares were issued in compensation for the elements of remuneration foregone in respect of the period 1 June 2018 to 31 January 2019, at a price of 28.0p per new Ordinary Share. The issue price reflects the Company's average share price during the period to which the compensation relates.

 

These new Ordinary Shares issued to the Directors were as follows:

 

Total holding after issue

 

Name

Number of new Ordinary Shares issued

Number of Ordinary Shares

% Enlarged issued share capital

 

 

Martin Perry

55,264

2,732,547

4.28%

 

David Steel

39,060

804,151

1.26%

 

Robin Pinchbeck

42,901

1,099,447

1.72%

 

Iain Paterson

42,901

506,065

0.79%

 

 

Application has been made for the 180,126 new Ordinary Shares to be admitted to trading on AIM which is expected to occur on 20 March 2019. Following the above issue of new Ordinary Shares, the number of Ordinary Shares (each carrying one vote) in issue is 63,885,427. There are no shares held in treasury. The figure of 63,885,427 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interests in, or a change to their interests in, the share capital of Enteq under the Disclosure and Transparency Rules.

 

 

For further information, please contact:

 

Enteq Upstream plc

+44 (0)1494 618739

Martin Perry, Chief Executive Officer

David Steel, Finance Director

 

 

Investec Bank plc (NOMAD and Broker)

+44 (0)207 597 4000

Chris Treneman, Patrick Robb, David Anderson

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

1. Martin Perry

2. David Steel

3. Iain Paterson

4. Robin Pinchbeck

2.

Reason for the notification

a)

Position/status

1. Chief Executive Officer

2. Finance Director

3. Chairman

4. Non-executive Director

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Enteq Upstream

b)

LEI

2138006BKS2MOAPRUB75

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1 pence each

 

GB00B41Q8Q68

b)

Nature of the transaction

Issue of shares in compensation for cash remuneration

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.280

1. 55,264

2. 39,060

3. 42,901

4. 42,901

d)

Aggregated information

Not applicable - single transaction

e)

Date of the transaction

12 March 2019

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOESFUFMLFUSEED
Date   Source Headline
10th Apr 20247:00 amRNSYear-end Trading Update
11th Jan 20249:12 amRNSHolding(s) in Company
8th Jan 20243:59 pmRNSHolding(s) in Company
24th Nov 20237:00 amRNSPresenting at the MelloLondon Conference
15th Nov 20237:00 amRNSHalf-year Report
2nd Nov 202310:25 amRNSDirector/PDMR Shareholding
30th Oct 20234:08 pmRNSResult of General Meeting
23rd Oct 20237:00 amRNSAwards under the Enteq Performance Share Plan
18th Oct 202311:07 amRNSInvestor Presentation via Investor Meet Company
10th Oct 20237:00 amRNSAppointment of Non-Executive Director
6th Oct 20232:25 pmRNSHolding(s) in Company
4th Oct 20237:00 amRNSHolding(s) in Company
29th Sep 20237:00 amRNSAGM Statement and Board Update
22nd Sep 20233:29 pmRNSNotice of Final Results
19th Sep 20232:53 pmRNSHolding(s) in Company
6th Sep 20237:00 amRNSNotice of Annual General Meeting
9th Aug 20238:25 amRNSSABER System Field Trial Update
31st Jul 20239:30 amRNSNotice of Final Results
1st Jun 20232:30 pmRNSIssue of Shares and Director/PDMR Shareholdings
1st Jun 20237:00 amRNSAppointment of new CFO
12th Apr 20237:00 amRNSSale of XXT and Year-end Trading Update
29th Mar 20237:08 amRNSSale of Property
15th Feb 20237:00 amRNSSABER Tool Update
16th Nov 20221:25 pmRNSDirector/PDMR Shareholding
16th Nov 20227:00 amRNSInterim Results
21st Sep 20223:36 pmRNSResult of AGM
21st Sep 20229:05 amRNSSecond Price Monitoring Extn
21st Sep 20229:00 amRNSPrice Monitoring Extension
21st Sep 20227:00 amRNSAGM Trading Statement
2nd Aug 20225:43 pmRNSIssue of Shares and Director/PDMR Shareholding
8th Jul 20223:10 pmRNSDirector/PDMR Shareholding
6th Jul 20227:00 amRNSFinal Results and Investor Presentation
14th Apr 20221:00 pmRNSDirector/PDMR Shareholding
7th Apr 20227:00 amRNSYear-end Trading Update
8th Mar 20229:06 amRNSHolding(s) in Company
3rd Mar 20221:47 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSBusiness Update and SABER Technology Progress
23rd Dec 202110:42 amRNSHolding(s) in Company
15th Dec 20213:39 pmRNSIssue of Shares and Director/PDMR Shareholding
18th Nov 20217:00 amRNSInterim Results
10th Nov 20217:00 amRNSExclusive Distributor Agreements Signed
8th Nov 20217:00 amRNSSABER Tool – Field Trial Update
28th Oct 20217:00 amRNSChange of Name
30th Sep 20214:05 pmRNSDirector/PDMR Shareholding
23rd Sep 20213:22 pmRNSResult of General Meeting and Change of Name
23rd Sep 20217:00 amRNSAGM Trading Statement
10th Aug 202110:30 amRNSDirector/PDMR Shareholding
26th Jul 20215:04 pmRNSDirector/PDMR Shareholding
14th Jul 20214:25 pmRNSIssue of shares and Director/PDMR Shareholding
7th Jul 20217:00 amRNSFinal Results & Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.